We have previously documented that dermcidin (DCD) acts as a survival factor in prostate cancer cells exposed to either hypoxia or oxidative stress (Stewart et al, 2007), and hepatoma cell lines subject to oxidative stress (Lowrie et al, 2006). Here, DCD is linked to hepatocellular carcinoma.